Klaria Pharma Holding - Crunchbase Company Profile & Funding

Q: Who invested in Klaria Pharma Holding?

Klaria Pharma Holding is funded by EISMEA.

Q: How much funding has Klaria Pharma Holding raised to date?

Klaria Pharma Holding has raised obfuscated.

Overview

Klaria Pharma Holding

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Klaria Pharma Holding

CB Rank

49655

Klaria's business concept is to develop and commercialize innovative products

Founded

obfuscation

Public

Post-IPO Debt

Uppsala, Uppsala Lan, Sweden

1-10

www.klaria.com/en

Pharmaceutical

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Fredrik Hübinette: Co-Founder & Chairman
Hans Richter: CFO

Details

Legal Name

Klaria AB

Operating Status

Active

Stock Symbol

STO:KLAR

Company Type

For Profit

Founders

Fredrik Hübinette, Scott Boyer

About the Company

Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative, rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses.

Phone Number

+46 (0) 8 446 42 99

Contact Email

info@klaria.com

Predictions & Insights

Growth Insight

See this Growth Insight

Klaria Pharma Holding is

Lorem

to be growing

Top Contributing Factors

Financial Decline

Growth Prediction

See this Growth Prediction

Products & Services

Sumatriptan Alginate Film

A pharmaceutical product for treating migraine via fast administration through the oral mucosa using patented alginate film technology.

Epinephrine Alginate Film

A research and development project for an alginate film delivering epinephrine to treat anaphylactic shock.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Klaria Pharma Holding	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
EISMEA	—	Grant - Klaria Pharma Holding	—
EISMEA	—	Grant - Klaria Pharma Holding	—
EISMEA	—	Grant - Klaria Pharma Holding	—
EISMEA	—	Grant - Klaria Pharma Holding	—
EISMEA	—	Grant - Klaria Pharma Holding	—